Search results for “Microsomal Prostaglandin E Synthase-1” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 164 patents, we discovered top 19 key players by total patent application. Glenmark Pharmaceuticals SA, AstraZeneca Pharmaceutical Co., Ltd., Biolipox AB are dominant in this area. They take 54.27% of the total patent filing.
Glenmark Pharmaceuticals SA
Neuchâtel, Switzerland
Patent: 38
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 28
Biolipox AB
Sweden
Patent: 23
Merck Frosst Canada & Co.
Canada
Patent: 20
Merck Canada, Inc.
Canada
Patent: 15
NovaSAID AB
STOCKHOLM, Sweden
Patent: 6
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 5
STARTUP
Gesynta Pharma AB
Sweden
Patent: 5
Shanghai Hengrui Pharmaceutical Co., Ltd.
Shanghai Shi, China
Patent: 5
Merck & Co., Inc.
New Jersey, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Gesynta Pharma AB
Sweden
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 6 patents applied in the last 5 years. We discover 1 most active companies in this area.
Glenmark Pharmaceuticals SA
Neuchâtel, Switzerland
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: